Please only contact T&T affiliates whose emails have a URL domain of “@ttscientific.com” or via our web forms.

Media

August 2022

T&T Scientific in One-Minute

Informative Media

Global Conference for Lipid Nanoparticles & Non viral Nanocarriers
By our own Alex Aust, MS, MBA

What Are Lipid Nanoparticles?
By our own Alex Aust, MS, MBA

What Are the Differences Between Liposomes and Lipid Nanoparticles?
By our own Alex Aust, MS, MBA

T&T cGMP Pharmaceutical Facility and Operation
By our own Alex Aust, MS, MBA

What Are the Manufacturing Capacities at T&T Scientific?
By our own Alex Aust, MS, MBA

Does T&T Scientific Run Large Quantity Batches Using Ethanol Injection Microfluidics for LNP Pharmaceutical Vaccines and Therapeutics?
By our own Alex Aust, MS, MBA

Does T&T Scientific Help with any Covid-19 Vaccines?
By our own Alex Aust, MS, MBA

T&T Scientific Manufacturing Technologies, Quality System and eQMS
By our own Alex Aust, MS, MBA

What Are the Differences Between Liposomes and Lipid Nanoparticles?
By our own Alex Aust, MS, MBA

Does T&T Scientific Have Electronic Quality Management System (eQMS)?
By our own Alex Aust, MS, MBA

What Are the Storage Capabilities at T&T Scientific?
By our own Alex Aust, MS, MBA

How Quickly Can T&T Release a Clinical Batch?
By our own Alex Aust, MS, MBA

What is T&T Scientific ProFECT LNP Formulation and Its Advantages?
By our own Alex Aust, MS, MBA

How T&T Scientific Maintain Confidentiality Between Its Clients?
By our own Alex Aust, MS, MBA

What Are the Most Common Sources for GMP Lipids?
By our own Alex Aust, MS, MBA

Lipid Demands and Manufacturing Race for Lipid Nanoparticles, the Building Blocks for mRNA Vaccines
By our own Alex Aust, MS, MBA

Lipids for Vaccines and Therapeutics: Meeting the Demand?
By our own Alex Aust, MS, MBA

Timeline and History of Development for Nucleic Acids Therapeutics and Vaccines?
By our own Alex Aust, MS, MBA

CRISPR Cas9 Gene Editing for Non viral Drug Delivery Protein, Antigen for Gene Editing Therapeutic
By our own Alex Aust, MS, MBA

Cellular Uptake & Expression of Lipid Nanoparticle mRNA in Vaccine Constructs
By our own Alex Aust, MS, MBA

What Type of Nanoparticles Are Used for mRNA Delivery and Covid Vaccines APIs? Why?
By our own Alex Aust, MS, MBA

Types of Lipid Based Drug Delivery Systems
By our own Alex Aust, MS, MBA

Types of Nanoparticles and the Type Used for Most Effective Covid Vaccines
By our own Alex Aust, MS, MBA

The State of Lipid Nanoparticle Formulation, Development, and Manufacturing
By our own Alex Aust, MS, MBA

Global Conference for Lipid Nanoparticles &
Other Non-viral Nanocarriers - 2021

by Dr. Gaurav Sahay (Keynote Speech) from the Oregon State University

Lipid Nanoparticles for Delivery of mRNA Therapeutics and Vaccines
by Dr. Gaurav Sahay (Keynote Speech)
from the Oregon State University

by Dr Vivek Gupta at St. John's University and PulmoSIM Therapeutics

Lipid-Based Delivery Systems for Respiratory Diseases
by Dr Vivek Gupta at St. John's University and PulmoSIM Therapeutics

by Mr. Greg Troiano at Translate Bio (Keynote Speech)

Overcoming Challenges of Nanomedicines Clinical and Commercial Supply Chain
by Mr. Greg Troiano at Translate Bio (Keynote Speech)

by Dr. Dariush Mohammadyani at Johnson and Johnson

Computational Approaches to Drug Delivery of RNA Therapeutics and Vaccines
by Dr. Dariush Mohammadyani at Johnson and Johnson

by Dr. Chandrashekhar V. Kulkarni at University of Central Lancashire

Beyond Liposomes: Hierarchically Organized Formulations
by Dr. Chandrashekhar V. Kulkarni at University of Central Lancashire

by Dr. Firas Al-Zubaydi at University of Baghdad

Lipid & Polymer Hybrid Nanoparticles: Emerging Approaches for Effective Drug Delivery
by Dr. Firas Al-Zubaydi at University of Baghdad

by Dr. Jayachandra Ramapuram at University of Auburn
Dr. Bruce Ramshaw, MD - Surgeon, Entrepreneur, and Former Chairman of Surgery at the University of Tennessee, CQInsights
by Dr. Valerio Pereno at Oxford Nanoimaging
by Dr. Eshu Middha at Luminicell
by Dr. Laila Kudsiova at University of Brighton
by Dr. Prof. Arote Rohidas from Seoul National University

Improvements for Oral Delivery of Pharmaceutical Nanomedicines
by Dr. Jayachandra Ramapuram at University of Auburn

Value-Based Innovation for The Future of Healthcare in The Real World
Dr. Bruce Ramshaw, MD - Surgeon, Entrepreneur, and Former Chairman of Surgery at the University of Tennessee, CQInsights

Vesicles Below the Diffraction Limit: Imaging with Super-Resolution
by Dr. Valerio Pereno at Oxford Nanoimaging 

Lipid-Based AIE Nanocarriers for Effective Nucleic Acids Delivery
by Dr. Eshu Middha at Luminicell

Novel Lipopolyplex & Lipid-based Gene Delivery Vectors for DNA and siRNA
by Dr. Laila Kudsiova at University of Brighton

Development of Multifunctional Nanomaterials for Gene Therapy Applications
by Dr. Prof. Arote Rohidas from Seoul National University


by Dr. Hardik Amin at Vaccine Design and Delivery Research Group at University of Montana

Redefining the Dogma of mRNA Formulations
by Dr. Hardik Amin at Vaccine Design and Delivery Research Group at University of Montana

by Dr. Jayesh Kulkarni at Nanomedicines Innovation Network (NMIN)

Mechanism of Lipid Nanoparticle Formulations
by Dr. Jayesh Kulkarni at Nanomedicines Innovation Network (NMIN)

By Dr. Vahid Raeesi from Precision Nanosystems

Microfluidic-designed Lipid Nanocarriers for Genetic Medicine Application
By Dr. Vahid Raeesi from Precision Nanosystems

By Mr. Dai Hayward from Micropore Technologies

Advances in Nanomedicine Manufacturing Technologies
By Mr. Dai Hayward from Micropore Technologies

Mr. Arun Kedia from Vav Life Sciences

The Choice of Lipid for
Vaccines and Therapeutics
Mr. Arun Kedia from Vav Life Sciences

Ms. May Guo, Trilink Biotechnologies Part of Maravai LifeScience

Enabling mRNA for
Vaccines and Therapeutics
Ms. May Guo, Trilink Biotechnologies
Part of Maravai LifeSciences

Ms. Kim Rice - Founder and CEO at Momentum Pharma Solutions, LLC,

Global Pharmaceutical Project Management, Product Launch, and Supply Chains, What Has Covid-19 Thought Us?
Ms. Kim Rice - Founder and CEO at Momentum Pharma Solutions, LLC,

T&T Scientific Alex Aust, MS, MBA

Establishing Modern & Flexible Tech Transfer Platform & Drug Product CDMO
By our own Alex Aust, MS, MBA

Mr. Dave Moore and Gerald Rea Dr. Gerald from Rea Toralgen

Working Toward Oral Delivery of Biologics
By Mr. Dave Moore and Gerald Rea Dr. Gerald from Rea Toralgen

Fun Highlights of the Conference

T&T Scientific in One Minute

Global Conference Preview